Regulatory Status of Compounded Peptides & Custom Formulas
When clinically appropriate and legally permissible, a physician may consider a compounded medication for an individual patient. Compounded medications are not FDA-approved and are subject to different regulatory requirements than FDA-approved drugs.
Not mass-market approved new drugs
Individual compounded peptide preparations are prepared for specific patients on a personalized basis and do not undergo New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) pre-market safety or efficacy reviews by the FDA.
Compounded pharmacy governance
All compounding partners utilized or recommended by PeptideDoc operate under state board of pharmacy licensing and federal CGMP (Current Good Manufacturing Practice) standards, yet individual compounds remain legally categorized as compounded drugs rather than FDA-approved manufactured biologics.
Individualized clinical supervision
Compounded peptides are administered solely under direct medical supervision following clinical history review, physical exam, and laboratory diagnostics.
